Skip to content

Effect of acute theacrine supplementation and exercise on mood, cognition, and health in young adults.

Evaluation of the effect of acute theacrine supplementation associated with a physical exercise program on mood, mental health, cognition, and health parameters of young individuals. - Heart rate variability (HRV) Heart rate variability (HRV)

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
REBEC
Registry ID
RBR-7f8rdnf
Enrollment
Unknown
Registered
2025-06-30
Start date
2024-10-09
Completion date
Unknown
Last updated
2025-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anxiety

Interventions

This is a randomized, double-blind, crossover clinical trial with two arms (theacrine and placebo). A total of 40 participants will be included, each undergoing two experimental sessions separated by

Sponsors

Universidade Federal do Rio de Janeiro Campus Macaé
Lead Sponsor
Universidade Federal do Rio de Janeiro Campus Macaé
Collaborator

Eligibility

Age
18 Years to 45 Years

Inclusion criteria

Inclusion criteria: Adults aged between 18 and 45 years; individuals engaged in resistance training for at least six months prior to the first study visit, to avoid delayed-onset muscle soreness typically observed in untrained individuals; with or without a diagnosis of common mental disorders (anxiety and/or depression); of both sexes

Exclusion criteria

Exclusion criteria: Osteoarthritis and rheumatoid arthritis; human immunodeficiency virus (HIV) infection; musculoskeletal disorders that prevent physical exercise; hypertension (systolic blood pressure above 120 mmHg and/or diastolic blood pressure above 80 mmHg); cardiovascular diseases; pregnancy and lactation; use of anticonvulsants; use of central nervous system stimulants, such as methylphenidate (Ritalin®, Concerta®), lisdexamfetamine (Vyvanse®, Juvene®), bupropion hydrochloride (Wellbutrin XL®, Zetron XL®, Bup), lithium carbonate (Carbolithium®); smokers, due to the stimulant effect of nicotine on the central nervous system. All information will be collected through anamnesis

Design outcomes

Primary

MeasureTime frame
It is expected that taking theacrine at a dose of 200 mg after a single session may improve anxiety;It is expected that taking theacrine at a dose of 200 mg after a single session may improve mood;It is expected that taking theacrine at a dose of 200 mg after a single session may improve cognition;It is expected to reduce the perception of effort and during exercise caused by theacrine

Secondary

MeasureTime frame
It is expected that taking theacrine in a single dose of 200 mg after a single session may improve heart rate variability;It is expected that taking theacrine in a single dose of 200 mg after a single session may improve blood glucose and lactate;It is expected that ingestion of theacrine in a single dose of 200 mg after a single session may improve exercise tolerance and preference

Countries

Brazil

Contacts

Public ContactGustavo de Oliveira

Universidade Federal do Rio de Janeiro Campus Macaé

gvo.vieira@gmail.com+55 22 999643431

Outcome results

None listed

Source: REBEC (via WHO ICTRP)